Novais Eduardo N, Hill Mary K, Carry Patrick M, Heyn Patricia C
Department of Orthopaedic Surgery, Children's Hospital Colorado, 13123 East 17th Avenue, B600, Aurora, CO, 80045, USA.
Department of Physical Medicine & Rehabilitation, University of Colorado School of Medicine, Denver, CO, USA.
Clin Orthop Relat Res. 2016 May;474(5):1166-77. doi: 10.1007/s11999-015-4590-5.
Osteonecrosis of the femoral head is a major complication that negatively impacts the clinical and radiographic long-term outcome after treatment of developmental hip dysplasia (DDH). There are conflicting results in the literature whether age at the time of closed or open reduction and a specific surgical approach are associated with osteonecrosis. Better understanding of the impact of age at reduction and surgical approach is important to reduce the risk of osteonecrosis in patients with DDH.
QUESTIONS/PURPOSES: We aimed to evaluate the association between occurrence of osteonecrosis and (1) age at closed reduction; (2) age at open reduction; and (3) medial versus anterior operative approaches.
A systematic review identified studies reporting osteonecrosis occurrence after treatment of DDH and at least 2 years of followup. This study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Methodologic quality was assessed using the methodologic index for nonrandomized studies. Generalized logistic models were used to estimate pooled odds ratios (ORs) in the meta-analysis. Sixty-six studies were included in the systematic review and 24 in the meta-analysis. Data on 481 hips treated by closed reduction and 584 hips treated by open reduction were available to evaluate the association between osteonecrosis and age. The association between osteonecrosis and operative approach was assessed using data on 364 hips treated by medial open reduction and 220 hips treated by anterior open reduction.
Age at reduction (> 12 months versus ≤ 12 months) was not associated with osteonecrosis after closed reduction (OR, 1.1; 95% confidence interval [CI], 0.4-3.2; p = 0.9) or open reduction (OR, 1.1; 95% CI, 0.7-1.9; p = 0.66). The overall, adjusted incidence of osteonecrosis (≥ Grade II) was 8.0% (95% CI, 2.8%-20.6%) among patients treated with closed reduction at or before 12 months of age and 8.4% (95% CI, 3.0%-21.5%) among those treated after 12 months. Similarly, the odds of osteonecrosis after open reduction did not differ between patients treated after the age of 12 months compared with those treated at or before 12 months (OR, 1.1; 95% CI, 0.7-1.9; p = 0.7). The incidence of osteonecrosis (≥ Grade II) was 18.3% (95% CI, 11.7%-27.4%) among patients who had index open reduction at or before 12 months of age and 20.0% (95% CI, 13.1%-29.4%) among those who had index open reduction after 12 months of age. Among hips treated with open reductions, there was no difference in osteonecrosis after medial versus anterior approaches (18.7% medial versus 19.6% anterior; OR, 1.1; 95% CI, 0.5-2.2; p = 0.9). Conclusions We did not find an association between closed or open reduction performed at or before 12 months of age and an increased risk of osteonecrosis of the femoral head. Delayed treatment past 1 year of age as a strategy to reduce the development of osteonecrosis was not supported by this meta-analysis. Open reduction through a medial or anterior approach may be recommended based on surgeon's preference, because we found no association between development of osteonecrosis and the type of surgical approach. However, many of the studies in the current literature are nonrandomized Level III or IV observational studies of inconsistent quality. Higher quality evidence is needed to better understand the effects of age at reduction and operative approach on the development of osteonecrosis after DDH treatment.
Level III, therapeutic study.
股骨头坏死是发育性髋关节发育不良(DDH)治疗后对临床和影像学长期预后产生负面影响的主要并发症。关于闭合复位或切开复位时的年龄以及特定手术方式是否与股骨头坏死相关,文献中的结果相互矛盾。更好地了解复位时年龄和手术方式的影响对于降低DDH患者发生股骨头坏死的风险很重要。
问题/目的:我们旨在评估股骨头坏死的发生与(1)闭合复位时的年龄;(2)切开复位时的年龄;以及(3)内侧与前方手术入路之间的关联。
一项系统评价纳入了报告DDH治疗后发生股骨头坏死且随访至少2年的研究。本研究按照系统评价和Meta分析的首选报告项目声明进行。使用非随机研究的方法学指标评估方法学质量。在Meta分析中使用广义逻辑模型估计合并比值比(OR)。系统评价纳入了66项研究,Meta分析纳入了24项研究。有481例接受闭合复位治疗的髋关节和584例接受切开复位治疗的髋关节的数据可用于评估股骨头坏死与年龄之间的关联。使用364例接受内侧切开复位治疗的髋关节和220例接受前方切开复位治疗的髋关节的数据评估股骨头坏死与手术入路之间的关联。
复位时的年龄(>12个月与≤12个月)与闭合复位(OR,1.1;95%置信区间[CI],0.4 - 3.2;p = 0.9)或切开复位(OR,1.1;95%CI,0.7 - 1.9;p = 0.66)后的股骨头坏死均无关联。在12个月及以内接受闭合复位治疗的患者中,股骨头坏死(≥Ⅱ级)的总体调整发病率为8.0%(95%CI,2.8% - 20.6%),在12个月以后接受治疗的患者中为8.4%(95%CI,3.0% - 21.5%)。同样,12个月以后接受切开复位治疗的患者与12个月及以内接受治疗的患者相比,切开复位后发生股骨头坏死的几率没有差异(OR,1.1;95%CI,0.7 - 1.9;p = 0.7)。在12个月及以内接受初次切开复位治疗的患者中,股骨头坏死(≥Ⅱ级)的发病率为18.3%(95%CI,11.7% - 27.4%),在12个月以后接受初次切开复位治疗的患者中为20.0%(95%CI,13.1% - 29.4%)。在接受切开复位治疗的髋关节中,内侧入路与前方入路后的股骨头坏死情况没有差异(内侧为18.7%,前方为19.6%;OR,1.1;95%CI,0.5 - 2.2;p = 0.9)。结论:我们未发现12个月及以内进行闭合或切开复位与股骨头坏死风险增加之间存在关联。本Meta分析不支持将1岁以后延迟治疗作为降低股骨头坏死发生率的策略。基于外科医生的偏好,可推荐采用内侧或前方入路进行切开复位,因为我们发现股骨头坏死的发生与手术入路类型之间无关联。然而,当前文献中的许多研究是质量不一致的非随机Ⅲ级或Ⅳ级观察性研究。需要更高质量的证据来更好地了解复位时年龄和手术入路对DDH治疗后股骨头坏死发生的影响。
Ⅲ级,治疗性研究。